Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Post Market
Current status date:
2016-09-29
Original market date: See footnote 1
1971-12-31
Product name:
TYLENOL NO.1 CAPLETS
DIN:
02181061
Product Monograph/Veterinary Labelling:
Date:
2014-08-06
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
88 Mcnabb Street
Markham
Ontario
Canada
L3R 5L2
Class:
Human
Dosage form(s):
Tablet
Route(s) of administration:
Oral
Number of active ingredient(s):
3
Schedule(s):
Narcotic (CDSA I)
American Hospital Formulary Service (AHFS): See footnote 3
28:08.92 , 28:08.08
Anatomical Therapeutic Chemical (ATC): See footnote 4
N02AJ06 CODEINE AND PARACETAMOL
Active ingredient group (AIG) number:See footnote5
0311391002
| Active ingredient(s) | Strength |
|---|---|
| ACETAMINOPHEN | 300 MG |
| CAFFEINE | 15 MG |
| CODEINE PHOSPHATE | 8 MG |